Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:49
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 56 条
[1]   Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor [J].
Ahn, HS ;
Foster, C ;
Boykow, G ;
Arik, L ;
SmithTorhan, A ;
Hesk, D ;
Chatterjee, M .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :350-356
[2]  
Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753
[3]   Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor [J].
Andrade-Gordon, P ;
Mayanoff, BE ;
Derian, CK ;
Zhang, HC ;
Addo, MF ;
Darrow, AL ;
Eckardt, AJ ;
Hoekstra, WJ ;
McComsey, DF ;
Oksenberg, D ;
Reynolds, EE ;
Santulli, RJ ;
Scarborough, RM ;
Smith, CE ;
White, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12257-12262
[4]   Ligand cross-reactivity within the protease-activated receptor family [J].
Blackhart, BD ;
Emilsson, K ;
Nguyen, D ;
Teng, W ;
Martelli, AJ ;
Nystedt, S ;
Sundelin, J ;
Scarborough, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16466-16471
[5]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[6]   Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2) [J].
Bono, F ;
Lamarche, I ;
Herbert, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (03) :762-764
[7]  
BRASS LF, 1994, J BIOL CHEM, V269, P2943
[8]   Thrombin receptor-activating peptides (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies [J].
Ceruso, MA ;
McComsey, DF ;
Leo, GC ;
Andrade-Gordon, P ;
Addo, MF ;
Scarborough, RM ;
Oksenberg, D ;
Maryanoff, BE .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) :2353-2371
[9]   Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo [J].
Cheung, WM ;
Andrade-Gordon, P ;
Derian, CK ;
Damiano, BP .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (01) :16-25
[10]   A protective role for protease-activated receptors in the airways [J].
Cocks, TM ;
Fong, B ;
Chow, JM ;
Anderson, GP ;
Frauman, AG ;
Goldie, RG ;
Henry, PJ ;
Carr, MJ ;
Hamilton, JR ;
Moffatt, JD .
NATURE, 1999, 398 (6723) :156-160